Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$EBS Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$3.49 down -1486.36% YoY • Reported revenue of $234.3M up 66.29% YoY • Emergent BioSolutions Inc. updated its full year 2026 forecast, now expecting total revenues of $645 million to $675 million, adjusted net income of $10 million to $30 million, and adjusted EBITDA of $130 million to $150 million.
2

Price since post

Full Details

Advertisement|Remove ads.